Skip to content

Testing and Interpretation of HER2 Protein Expression and Gene Amplification in Urothelial Carcinoma

We report preliminary results from an ongoing evaluation of HER2 protein expression and gene amplification in la/mUC using optimized, UC-specific immunohistochemistry (IHC) and gene amplification in situ hybridization (ISH) assays.

{{assetTitle}}

Authors {{assetAuthors}}

Published date{{formattedPublishDate}}

{{assetDescription}}

Send Via Email

You are Leaving Medically

By following this link, you are leaving Roche Website and entering a site that is not owned or controlled by Roche. Roche does not take any responsibility for acces to or use of this website, nor for any content therein.

Leave Site

You are Leaving the Global Medically Site

By following this link, you are being redirected to another Roche page.

Leave Site Stay on Medically